{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:25:42Z","timestamp":1777479942749,"version":"3.51.4"},"reference-count":26,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2020,3,31]]},"DOI":"10.3233\/cbm-191204","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T12:38:40Z","timestamp":1582029520000},"page":"525-532","source":"Crossref","is-referenced-by-count":10,"title":["Survival prediction for patients with lung adenocarcinoma: A prognostic risk model based on gene mutations"],"prefix":"10.1177","volume":"27","author":[{"given":"Hua","family":"Geng","sequence":"first","affiliation":[{"name":"Department of Pathology, Tianjin Chest Hospital, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixiong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tianjin Chest Hospital, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixian","family":"Guo","sequence":"additional","affiliation":[{"name":"Tianjin Marvel Medical Laboratory, Tianjin Marvelbio Technology Co., Ltd, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Yan","sequence":"additional","affiliation":[{"name":"Tianjin Marvel Medical Laboratory, Tianjin Marvelbio Technology Co., Ltd, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuebin","family":"Han","sequence":"additional","affiliation":[{"name":"Tianjin Marvel Medical Laboratory, Tianjin Marvelbio Technology Co., Ltd, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meilin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tianjin Chest Hospital, Tianjin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanzhi","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/CBM-191204_ref1","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.3233\/CBM-191204_ref2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41419-017-0063-y","article-title":"Cell death-based treatment of lung adenocarcinoma","volume":"9","author":"Denisenko","year":"2018","journal-title":"Cell Death & Disease"},{"key":"10.3233\/CBM-191204_ref3","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.21037\/jtd.2018.03.143","article-title":"Factors associated with the prognosis and long-term survival of patients with metastatic lung adenocarcinoma: a retrospective analysis","volume":"10","author":"Huang","year":"2018","journal-title":"Journal of Thoracic Disease"},{"key":"10.3233\/CBM-191204_ref4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2217\/imt-2016-0150","article-title":"PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: Updated survival data","volume":"9","author":"Aguiar","year":"2017","journal-title":"Immunotherapy"},{"key":"10.3233\/CBM-191204_ref5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s11523-018-0594-x","article-title":"EGFR amplification and sensitizing mutations correlate with survival in lung adenocarcinoma patients treated with erlotinib (MutP-CLICaP)","volume":"13","author":"Ruiz-Pati\u00f1o","year":"2018","journal-title":"Targeted Oncology"},{"key":"10.3233\/CBM-191204_ref6","doi-asserted-by":"crossref","first-page":"e0120852","DOI":"10.1371\/journal.pone.0120852","article-title":"Identification of five driver gene mutations in patients with treatment-na? Lung adenocarcinoma in Taiwan","volume":"10","author":"Hsu","year":"2015","journal-title":"PLOS ONE"},{"key":"10.3233\/CBM-191204_ref7","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/bjc.1997.194","article-title":"K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer","volume":"78","author":"Fukuyama","year":"1997","journal-title":"Br J Cancer"},{"key":"10.3233\/CBM-191204_ref8","first-page":"497","article-title":"PIK3CA gene mutation associated with poor prognosis of lung adenocarcinoma","volume":"6","author":"Zhang","year":"2013","journal-title":"Oncotargets & Therapy"},{"key":"10.3233\/CBM-191204_ref9","first-page":"367","article-title":"K-rasgene mutations: An unfavorable prognostic marker in stage I lung adenocarcinoma","volume":"424","author":"Silini","year":"1994","journal-title":"Virchows Archiv An International Journal of Patholog"},{"key":"10.3233\/CBM-191204_ref10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10059-013-0060-7","article-title":"Wif1hypermethylation as unfavorable prognosis of non-small cell lung cancers with EGFR mutation","volume":"36","author":"Su","year":"2013","journal-title":"Molecules & Cell"},{"key":"10.3233\/CBM-191204_ref11","first-page":"147","article-title":"PET-CT in presurgical lymph node staging in non-small cell lung cancer: the importance of false-negative and false-positive findings","volume":"59","author":"Ab","year":"2017","journal-title":"Radiologia"},{"key":"10.3233\/CBM-191204_ref12","first-page":"267","article-title":"Regression shrinkage and selection via the lasso: A retrospective","volume":"73","author":"Tibshirani","year":"2011","journal-title":"Journal of the Royal Statistical Society"},{"key":"10.3233\/CBM-191204_ref13","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41591-018-0019-5","article-title":"Author correction: Mutations in the SWI\/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer","volume":"24","author":"Lissanu","year":"2018","journal-title":"Nature Medicine"},{"key":"10.3233\/CBM-191204_ref14","doi-asserted-by":"crossref","first-page":"e35073","DOI":"10.7554\/eLife.35073","article-title":"BRG1 governs glucocorticoid receptor interactions with chromatin and pioneer factors across the genome","volume":"7","author":"Hoffman","year":"2018","journal-title":"Elife"},{"key":"10.3233\/CBM-191204_ref15","doi-asserted-by":"crossref","first-page":"e36530","DOI":"10.1371\/journal.pone.0036530","article-title":"Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation","volume":"7","author":"Wilkerson","year":"2012","journal-title":"PLoS One"},{"key":"10.3233\/CBM-191204_ref16","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1200\/JCO.2008.19.7053","article-title":"Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis","volume":"27","author":"Tomida","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.3233\/CBM-191204_ref17","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1158\/0008-5472.CAN-06-1191","article-title":"Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung","volume":"66","author":"Raponi","year":"2006","journal-title":"Cancer Res"},{"key":"10.3233\/CBM-191204_ref18","doi-asserted-by":"crossref","first-page":"6486","DOI":"10.1158\/0008-5472.CAN-14-0061","article-title":"BRG1\/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization","volume":"74","author":"Tess","year":"2014","journal-title":"Cancer Research"},{"key":"10.3233\/CBM-191204_ref19","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1074\/jbc.RA118.003450","article-title":"The stimulatory G protein Gs\u03b1 is required in melanocortin 4 receptor-expressing cells for normal energy balance, thermogenesis and glucose metabolism","volume":"293","author":"Podyma","year":"2018","journal-title":"Journal of Biological Chemistry"},{"key":"10.3233\/CBM-191204_ref20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.lungcan.2012.11.003","article-title":"The T393C polymorphism of GNAS1 is a predictor for relapse and survival in resectable non-small cell lung cancer","volume":"79","author":"Uzunoglu","year":"2013","journal-title":"Lung Cancer"},{"key":"10.3233\/CBM-191204_ref21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4251\/wjgo.v6.i12.444","article-title":"TT genotype of GNAS1 T393C polymorphism predicts better outcome of advanced non-small cell lung cancer patients","volume":"6","author":"Gong","year":"2014","journal-title":"World Journal of Gastrointestinal Oncology"},{"key":"10.3233\/CBM-191204_ref22","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s00280-012-1849-3","article-title":"The T393C polymorphism of GNAS1 as a predictor for chemotherapy sensitivity and survival in advanced non-small-cell lung cancer patients treated with gemcitabine plus platinum","volume":"69","author":"Xie","year":"2012","journal-title":"Cancer Chemotherapy & Pharmacology"},{"key":"10.3233\/CBM-191204_ref23","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/dmcn.13769","article-title":"Genetic and imaging features of cerebellar abnormalities in tuberous sclerosis complex: more insights into their pathogenesis","volume":"60","author":"Renzo","year":"2018","journal-title":"Developmental Medicine & Child Neurology"},{"key":"10.3233\/CBM-191204_ref24","doi-asserted-by":"crossref","unstructured":"R. Pal, Y. Xiong and M. Sardiello, Abnormal glycogen storage in tuberous sclerosis complex caused by impairment of mTORC1 \u2013 dependent and \u2013 independent signaling pathways, Proc Natl Acad Sci U S A 116 (2019), 2977\u20132986.","DOI":"10.1073\/pnas.1812943116"},{"key":"10.3233\/CBM-191204_ref25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12881-018-0611-z","article-title":"A novel TSC2 missense variant associated with a variable phenotype of tuberous sclerosis complex: Case report of a Chinese family","volume":"19","author":"Wang","year":"2018","journal-title":"BMC Med Genet"},{"key":"10.3233\/CBM-191204_ref26","doi-asserted-by":"crossref","first-page":"a002220","DOI":"10.1101\/mcs.a002220","article-title":"Exceptional response to everolimus in a novel tuberous sclerosis complex-2 mutation-associated metastatic renal-cell carcinoma","volume":"4","author":"Alsidawi","year":"2018","journal-title":"Molecular Case Studies"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-191204","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:07:28Z","timestamp":1777385248000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-191204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":26,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/cbm-191204","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,31]]}}}